Inactive Instrument

Insiders Cyxone AB (publ) Nasdaq Stockholm

Equities

Sweden's Cyxone Appoints New CEO	04-22	MT
Cyxone AB Announces Chief Executive Officer Changes	04-22	CI
Cyxone AB Announces Board Changes	30/05/23	CI
Cyxone : Nomination Committee proposals and reasoned statement	26/04/23	PU
Cyxone AB Announces Board Resignations	26/04/23	CI
Cyxone Confirms Acting CEO with Permanent Appointment	13/12/22	MT
Cyxone AB Appoints Carl-Magnus Högerkorp as Permanent CEO	13/12/22	CI
Nomination committee appointed for Cyxone Annual General Meeting 2023	08/11/22	AQ
Cyxone AB Announces That the Members of the Nomination Committee for Annual General Meeting 2023	08/11/22	CI
Cyxone Appoints Erika Samuelsson as Chief Development Officer	22/09/22	CI
Biotech Company Cyxone Appoints New Chief Development Officer	02/09/22	MT
Cyxone AB Appoints Erika Samuelsson as Chief Development Officer	02/09/22	CI
Swedish Drugmaker Cyxone CEO Departs	21/06/22	MT
Cyxone Announces Executive Changes	20/06/22	CI
Cyxone : Instruction and charter for the Nomination Committee	12/04/22	PU
Swedish Biotech Firm Cyxone's Chief Medical Officer Exits	23/02/22	MT
Cyxone Announces Resignation of Cornel Pater as Chief Medical Officer	23/02/22	CI
Cyxone AB Appoints Cornel Pater as New Chief Medical Officer	01/09/21	CI
Cyxone AB Appoints Ola Skanung as Senior Executive Advisor	09/06/21	CI
Cyxone AB Elects Peter Heinrich and Alejandra Mørk as New Board Members	03/06/21	CI

No results for this search